FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
Listen to an audio podcast of the April 24, 2020 FDA Drug Safety Communication: FDA cautions against...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Listen to an audio podcast of the April 24, 2020 FDA Drug Safety Communication: FDA cautions against...
Source route
Continue on fda.gov
Leave the platform to read the original full article on the publisher site.
Source: FDA Drug Approvals
Scope: Regulatory
Related coverage
More related coverage
What's New Related to Drugs
Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety...
Epinephrine Auto-Injector Devices by Amneal and Impax: CDER Alert - FDA Alerts Patients and Health Care Professionals About Device Malfunction
FDA is alerting the public to immediately inspect certain lots of Amneal and Impax epinephrine auto-...
What’s New for Biologics
Latest news from the Center for Biologics Evaluation and Research
eSubmitter Application History
History of all updates to the application software in reverse chronological order by version number